HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

20.220

-0.160-0.79%

Volume:21.50K

Turnover:438.62K

Market Cap:8.31B

PE:2.65K

High:20.660

Open:20.360

Low:20.200

Close:20.380

52wk High:48.800

52wk Low:18.100

Shares:411.00M

HK Float Shares:302.00M

Volume Ratio:0.20

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.008

ROE:0.21%

ROA:-0.83%

PB:4.89

PE(LYR):2,645.21

PS:16.59

Loading ...

Overview Company News Filings

CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve

CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares

Bulletin Express

CF PHARMTECH Repurchases Shares for HK$382,300

CF PHARMTECH Repurchases Shares Valued at HK$348,200

CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000

Bulletin Express

CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22

CF PHARMTECH Repurchases Shares Valued at HK$418,700

CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares

Bulletin Express

CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share

CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9

How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors

Simply Wall St.

CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000

Bulletin Express

CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2

CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%

Bulletin Express

CF PHARMTECH (02652) Spends HK$218,000 on Share Buyback on March 31

CF PharmTech's Profit Slumps in 2025

MT Newswires Live

CF PHARMTECH (02652) Announces Annual Results with Adjusted Profit of 31.75 Million Yuan, Advances Transition to Global Inhalation System Platform

CF Pharmtech FY25 profit drops 88.2% to RMB 2.5 million

CF PharmTech Flags Expected Decline in 2025 Profit

MT Newswires Live

CF PharmTech to Partner With JD Health on Product Launches

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02652/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":20.22,"timestamp":1780452705160,"preClose":20.38,"halted":0,"volume":21500,"delay":0,"changeRate":-0.007850834151128566,"floatShares":302000000,"shares":411000000,"eps":0.00764371395436309,"marketStatus":"Trading","change":-0.16,"latestTime":"06-03 10:14:14","open":20.36,"high":20.66,"low":20.2,"amount":438620,"amplitude":0.022571,"askPrice":20.32,"askSize":1000,"bidPrice":20.22,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.00764371395436309,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1780459200000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20.38,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0.200645,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.007644,"volumeRatio":0.200645,"shares":411000000,"dividePrice":0,"high":20.66,"amplitude":0.022571,"preClose":20.38,"low":20.2,"week52Low":18.1,"pbRate":"4.89","psRate":"16.59","week52High":48.8,"institutionHeld":0,"latestPrice":20.22,"committee":-0.333333,"eps":0.00764371395436309,"divideRate":0,"volume":21500,"delay":0,"ttmEps":0.00764371395436309,"open":20.36,"prevYearClose":35,"prevWeekClose":22.22,"prevMonthClose":22.22,"prevQuarterClose":22.16,"fiveDayClose":19.66,"twentyDayClose":22.02,"sixtyDayClose":37.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-06-01","current":2665.19987,"percent":0.839744,"low":-293.764894,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"high":3595.964728,"avg":1098.551773,"sd":1175.771413,"marketCap":8746652155},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-01","current":3038.815931,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"marketCap":8746652155}],"updateTime":1780422376486},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197030790","title":"CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve","url":"https://stock-news.laohu8.com/highlight/detail?id=1197030790","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197030790?lang=en_us&edition=fundamental","pubTime":"2026-04-27 11:20","pubTimestamp":1777260037,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced on April 27, 2026, a key clinical advancement in the field of respiratory interventional medical device treatment. The first patient treated with its independently...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199558495","title":"CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1199558495","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199558495?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:23","pubTimestamp":1777040618,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share) disclosed a Next Day Return confirming the on-market repurchase of 18,500 ordinary shares on 24 April 2026. The buyback was executed at prices ranging from HK$20.54 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166048292","title":"CF PHARMTECH Repurchases Shares for HK$382,300","url":"https://stock-news.laohu8.com/highlight/detail?id=1166048292","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166048292?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:08","pubTimestamp":1777039712,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 24, 2026, the company repurchased 18,500 shares at a total cost of HK$382,300.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160206791","title":"CF PHARMTECH Repurchases Shares Valued at HK$348,200","url":"https://stock-news.laohu8.com/highlight/detail?id=1160206791","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160206791?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:27","pubTimestamp":1776950821,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 23, 2026, the company repurchased 16,500 of its own shares at a total cost of HK$348,200. The repurchase price per share ranged between HK$20.9 and HK$21.34.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158174705","title":"CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1158174705","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158174705?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:23","pubTimestamp":1776950636,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a share repurchase on 23 April 2026, executing its mandate approved on 16 December 2025. Key transaction details   • Shares repurchased: 16,500 ordinary H-shares,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199159525","title":"CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1199159525","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199159525?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:08","pubTimestamp":1776856133,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 22, 2026, the company repurchased 9,500 of its shares at a cost of HK$208,700. The price per share ranged between HK$21.88 and HK$22.10.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196574474","title":"CF PHARMTECH Repurchases Shares Valued at HK$418,700","url":"https://stock-news.laohu8.com/highlight/detail?id=1196574474","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196574474?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:25","pubTimestamp":1776695107,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 20, 2026, the company repurchased 18,500 shares at a cost of HK$418,700. The repurchase price ranged from HK$22.48 to HK$22.86 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114187900","title":"CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1114187900","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114187900?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:23","pubTimestamp":1776695034,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share) reported the repurchase of 18,500 shares on 20 April 2026 under its existing mandate approved on 16 December 2025. The on-exchange purchases were executed within a price...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729257","title":"CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729257","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628729257?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:18","pubTimestamp":1776694692,"startTime":"0","endTime":"0","summary":"CF PharmTech reported repurchase of 18,500 H shares on April 20.Buyback price ranged from HKD 22.48 to HKD 22.86 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL4N9sPl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132065643","title":"CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1132065643","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132065643?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:58","pubTimestamp":1775732304,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 9, 2026, the company repurchased 13,000 shares at a total cost of HK$296,800. The repurchase price per share ranged from HK$22.56 to HK$23.00.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625605898","title":"How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2625605898","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625605898?lang=en_us&edition=fundamental","pubTime":"2026-04-06 22:16","pubTimestamp":1775484997,"startTime":"0","endTime":"0","summary":"On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together.\nAlongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/how-jd-healths-cf-pharmtech-alliance-and-equity-awards-strat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/how-jd-healths-cf-pharmtech-alliance-and-equity-awards-strat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000306685.HKD","BK4526","BK1591","CHAT","ARTY","IE00BGV7N243.SGD","BK4505","LU1688375341.USD","BK4211","SG9999002463.SGD","BK4215","BK4509","BK4614","LU0463099449.HKD","BK4588","LU0244354667.USD","LU0456827905.SGD","BK4504","BK1583","BK1515","BK4122","BK4558","BK1142","BK4503","06618","02652","BK4524","BK4531","LU0326950275.SGD","BK4579","LU0588546209.SGD","BK4093","BK4220","BK4585","86618","HK0000306701.USD","SGXZ62798434.SGD","AI","BK1615","HK0000320223.HKD","HK0000320264.USD","AIPO","BK1571","KJD","09618","LU1880383366.USD","LU0106959298.USD","BK1247","IE0008368742.USD","BK1589","LU0307460666.USD","SGXZ86797644.SGD","LU0051755006.USD","BK4551","LU1188198961.HKD","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186649255","title":"CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1186649255","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186649255?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:43","pubTimestamp":1775126584,"startTime":"0","endTime":"0","summary":"On 2 April 2026, CF PharmTech, Inc. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange detailing the on-market buyback of 20,000 H shares. The shares were repurchased at prices...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111653616","title":"CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1111653616","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111653616?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:30","pubTimestamp":1775125813,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 2, the company repurchased 20,000 of its own shares at a total cost of approximately HK$456,700.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103936432","title":"CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103936432","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103936432?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:44","pubTimestamp":1774953888,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a small-scale share buyback executed on 31 March 2026. The company repurchased 9,500 H-shares on the Hong Kong Stock Exchange at prices ranging between HK$22.90 and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134057733","title":"CF PHARMTECH (02652) Spends HK$218,000 on Share Buyback on March 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1134057733","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134057733?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953636,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on March 31, 2026, the company repurchased 9,500 of its own shares at a total cost of HK$218,000.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318387","title":"CF PharmTech's Profit Slumps in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318387","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623318387?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:01","pubTimestamp":1774861313,"startTime":"0","endTime":"0","summary":"CF PharmTech's  profit attributable to owners of the parent fell to 2.5 million yuan for 2025 from 21.1 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Earnings per share came in at 0.0066 yuan, compared with 0.0569 yuan a year earlier.Revenue declined to 432.5 million yuan from 607.8 million yuan in 2024.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CF","02652","BK4588","BK4585","BK4093","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135167999","title":"CF PHARMTECH (02652) Announces Annual Results with Adjusted Profit of 31.75 Million Yuan, Advances Transition to Global Inhalation System Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1135167999","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135167999?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:50","pubTimestamp":1774860646,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has released its annual results for the period ending December 31, 2025. The Group reported revenue of 433 million yuan (Renminbi), gross profit of 328 million yuan, profit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397797","title":"CF Pharmtech FY25 profit drops 88.2% to RMB 2.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397797","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623397797?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:32","pubTimestamp":1774859529,"startTime":"0","endTime":"0","summary":"CF PharmTech posted net income attributable to owners of RMB 2.5 million, down 88.22%.Gross margin narrowed 5.1 percentage points to 75.8% on lower CF017 pricing under VBP renewal and a mix shift toward lower-margin CF018.CF017 revenue dropped to RMB 340 million, while CF018 climbed to RMB 79 million; overseas revenue topped RMB 10 million, with cumulative overseas orders exceeding 16 million units.Management expects 2026 to be a year of resumed growth as CF017 procurement and execution normalize, supported by channel partnerships spanning primary care and online distribution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL4wY27L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621572163","title":"CF PharmTech Flags Expected Decline in 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2621572163","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621572163?lang=en_us&edition=fundamental","pubTime":"2026-03-23 12:44","pubTimestamp":1774241069,"startTime":"0","endTime":"0","summary":"CF PharmTech  said it expects 2 million yuan to 3 million yuan in attributable profit for 2025, down from 21.1 million yuan in 2024, according to a Hong Kong bourse filing Friday.Shares of the pharmaceutical firm fell nearly 2% in late morning trade Monday.The drop in profit comes amid an expected decline in revenue to 410 million yuan to 450 million yuan from 607.8 million yuan in 2024.The company's financial results are due by the end of March.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK4585","CF","02652","BK4588","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621287887","title":"CF PharmTech to Partner With JD Health on Product Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2621287887","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621287887?lang=en_us&edition=fundamental","pubTime":"2026-03-23 09:45","pubTimestamp":1774230357,"startTime":"0","endTime":"0","summary":"CF PharmTech  is partnering with JD Health International  to launch a number of respiratory and rhinology therapeutic products, according to a Hong Kong bourse filing Monday.The firm said JD Health will serve as the exclusive online launch platform for a number of products over the next three years.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000320264.USD","HK0000306701.USD","LU0456827905.SGD","LU0106959298.USD","BK4504","BK1591","BK4503","BK1191","LU0244354667.USD","LU1188198961.HKD","LU0326950275.SGD","SGXZ62798434.SGD","BK1515","BK4509","HK0000306685.HKD","LU0307460666.USD","06618","BK4531","BK4579","BK1571","LU1880383366.USD","IE00BGV7N243.SGD","LU0588546209.SGD","BK1247","BK4505","BK4526","BK4558","BK4093","02652","BK1589","HK0000320223.HKD","BK1615","86618","BK4524","BK4122","SGXZ86797644.SGD","KJD","BK1583","LU0463099449.HKD","IE0008368742.USD","LU1688375341.USD","BK4585","BK4551","BK4220","LU0051755006.USD","SG9999002463.SGD","BK4614","BK4588","BK1142"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":185,"code":"91000000","status":"200"}]}}